PublishedOpen AccessResearch PaperTransparent Peer ReviewedCC BY 4.0
ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
Pharmacovigilance and Drug Safety
Authors
Amit Singh , DR. Neeraj Bhandari , Ashish Kumar , Ajay Kumar , Jyoti Devi
Keywords
Abstract
Pharmacovigilance keeps an eye out for and assesses adverse drug reactions (ADRs), which help ensure that drugs are used safely and appropriately. Even with the extensive testing that medications go through before being approved, some side effects might not be seen until the medication is taken widely. One important way to find new safety signals is through the spontaneous reporting of adverse drug reactions (ADRs) by patients and healthcare providers. Understanding the safety profile of medications is further assisted by observational studies and post-marketing surveillance that make use of real-world data.
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"Pharmacovigilance and Drug Safety", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 1, page no.a730-a735, January-2025, Available :https://ijrti.org/papers/IJRTI2501088.pdf
APA — 7th edition
Singh, A., Bhandari, N., Kumar, A., Kumar, A., & Devi, J. (2025). Pharmacovigilance and Drug Safety. International Journal for Research Trends and Innovation, 10(1), a730-a735. https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088
MLA — 9th edition
Singh, Amit, et al. "Pharmacovigilance and Drug Safety." International Journal for Research Trends and Innovation, vol. 10, no. 1, 2025, pp. a730-a735, https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088.
Chicago — 17th, bibliography
Singh, Amit, et al. "Pharmacovigilance and Drug Safety." International Journal for Research Trends and Innovation 10, no. 1 (2025): a730-a735. https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088.
Harvard — author–date
Singh, A. et al. (2025) 'Pharmacovigilance and Drug Safety', International Journal for Research Trends and Innovation, 10(1), pp. a730-a735. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088
IEEE — numbered reference
A. Singh, N. Bhandari, A. Kumar, A. Kumar and J. Devi, "Pharmacovigilance and Drug Safety," IJRTI, vol. 10, no. 1, pp. a730-a735, Jan. 2025.
Vancouver — biomedical
Singh A, Bhandari N, Kumar A, Kumar A, Devi J. Pharmacovigilance and Drug Safety. IJRTI. 2025 Jan;10(1):a730-a735.
AMA — 11th edition
Singh A, Bhandari N, Kumar A, Kumar A, Devi J. Pharmacovigilance and Drug Safety. IJRTI. 2025;10(1):a730-a735. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2501088,
author = {Amit Singh and Neeraj Bhandari and Ashish Kumar and Ajay Kumar and Jyoti Devi},
title = {Pharmacovigilance and Drug Safety},
journal = {International Journal for Research Trends and Innovation},
volume = {10},
number = {1},
pages = {a730-a735},
year = {2025},
month = {January},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Singh, Amit
AU - Bhandari, Neeraj
AU - Kumar, Ashish
AU - Kumar, Ajay
AU - Devi, Jyoti
TI - Pharmacovigilance and Drug Safety
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 10
IS - 1
PY - 2025
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2501088
SP - a730-a735
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.